RUNX1 and colorectal carcinoma: Similarly, we experimentally showed that RUNX1 operates as a positive regulator of PTGS2 expression in HCT116 CRC cells by promoting transcriptional activation of the PTGS2 promoter via the 1086–1096 bp binding motif.